A polyp is a growth that projects outward from the lining of a body cavity, while a tumor is any abnormal mass of tissue that grows where it should not. The two terms overlap more than most people realize: some polyps are tumors, some tumors start as polyps, and many polyps are neither cancerous nor on their way to becoming cancerous. The distinction matters because doctors treat a harmless polyp very differently from a malignant tumor, yet the line between the two can be surprisingly blurry under a microscope.
Why the Two Terms Overlap
The word “polyp” describes a shape, not a diagnosis. If tissue bulges outward from a mucous membrane on a stalk or a broad base, clinicians call it a polyp. It says nothing about whether the cells inside are normal, precancerous, or already malignant. You can have a polyp in your colon, your uterus, your nasal passages, your stomach, or your vocal cords, and each one could be a completely different type of tissue behaving in a completely different way.
“Tumor,” on the other hand, describes behavior. A tumor is a mass of cells that multiplies beyond the body’s normal controls. It can be benign, meaning it grows but does not invade surrounding tissue or spread, or malignant, meaning it invades and can metastasize. The catch is that a polyp made up of abnormally proliferating cells is, by definition, also a tumor. A small adenomatous polyp in the colon is both a polyp (it sticks out from the lining) and a neoplasm (its cells are dividing in a disorganized way). A fibroid in the uterine wall, by contrast, is a tumor but not a polyp, because it grows within the muscle layer rather than protruding into a cavity.
Types of Polyps and Which Ones Carry Risk
Not every polyp has the potential to turn dangerous. The broad categories split along a simple line: is the polyp made of cells that are growing abnormally (neoplastic), or is it just an overgrowth of normal-looking tissue (non-neoplastic)?
- Adenomatous polyps: These are the classic precancerous polyps found in the colon. Their cells show disorganized growth patterns, and if left in place long enough, a fraction of them accumulate further genetic damage and progress to cancer.
- Hyperplastic polyps: Generally small and considered low-risk. They are the most common polyps found during colonoscopy, and most never progress to anything worrisome.
- Serrated polyps: A category that has received intense research attention because they look superficially similar to hyperplastic polyps but can follow a distinct molecular route to cancer. Sessile serrated adenomas and traditional serrated adenomas fall into this group.
- Hamartomatous polyps: Made of a disorganized but otherwise normal mixture of tissues. On their own they are benign, but certain inherited syndromes that produce many hamartomatous polyps carry a real cancer risk over a lifetime.
- Inflammatory polyps: Formed in response to chronic inflammation, as in inflammatory bowel disease. They are not inherently precancerous, though the underlying inflammation itself raises cancer risk.
Hamartomatous polyps illustrate the overlap problem well. Individually, they are benign growths. But in hereditary syndromes that produce hundreds of them, the cumulative risk of colorectal and other cancers climbs substantially.1PubMed Central. Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood So even a “benign” polyp type can be a red flag depending on context.
How a Polyp Becomes a Cancerous Tumor
The best-understood progression is the adenoma-to-carcinoma sequence in the colon. A normal cell in the intestinal lining picks up a mutation that gives it a slight growth advantage. Over years, that small cluster of abnormal cells forms a visible polyp. Additional mutations pile up, the cells become increasingly disorganized, and eventually some of them gain the ability to invade deeper layers of the bowel wall. At that point the polyp has become a cancer.
One of the earliest and most common mutations in this sequence involves a gene called APC. When APC is working properly, it helps keep a major growth-signaling pathway in check. When both copies of the gene are knocked out by mutations, that brake is released and cell proliferation ramps up. This is considered the initiating event in the vast majority of colorectal cancers.2PubMed Central. Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer The mutations that follow, in genes that control DNA repair, cell death, and further growth signaling, determine whether and how quickly the polyp progresses.3PubMed Central. Pathways of Colorectal Carcinogenesis
Research into the specific survival signals that keep precancerous cells alive has shown that different proteins matter at different stages. Early on, a protein called BCL-2 is important for the initial transformation of stem cells. But as the adenoma grows and edges toward malignancy, a related protein called BCL-XL becomes the critical survival factor throughout the rest of the sequence.4PubMed Central. BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer This kind of detail matters for developing targeted drugs, but for the average person the takeaway is simpler: the journey from harmless polyp to cancer is long, involves multiple genetic accidents, and can be interrupted by removing the polyp before those accidents accumulate.
The Serrated Pathway and Why It Complicates Things
The classic adenoma-to-carcinoma sequence is not the only route to colon cancer. Serrated polyps can progress through a completely different molecular pathway driven by mutations in genes called BRAF and K-ras. These mutations interfere with normal cell death, causing the cells to pile up in a characteristic saw-tooth architecture that pathologists call “serrated.”5Europe PMC / Thieme. Management of serrated adenomas and hyperplastic polyps
The problem for patients and doctors alike is that serrated polyps can be flat and pale, making them easy to miss during a colonoscopy. They also tend to appear in the right side of the colon, which is harder to examine thoroughly. For years, many of these lesions were lumped in with ordinary hyperplastic polyps and dismissed. The recognition that sessile serrated adenomas and traditional serrated adenomas have genuine malignant potential has changed screening and surveillance guidelines over the past two decades. If your colonoscopy report mentions a serrated lesion, it does not automatically mean cancer, but it does mean your doctor will want to keep a closer eye on you than if only tiny hyperplastic polyps were found.
When a Polyp Already Contains Cancer
Sometimes a polyp removed during colonoscopy turns out to already harbor cancer cells when the pathologist examines it under a microscope. Clinicians call this a “malignant polyp,” and the critical question becomes: has the cancer been completely removed, or does the patient need surgery?
The answer depends on how deeply the cancer cells have penetrated and several other features the pathologist evaluates. A cancerous polyp is classified based on whether malignant cells have broken through the thin muscle layer just beneath the surface lining (the muscularis mucosae) and invaded into the deeper submucosa. If cancer cells have not crossed that boundary, polypectomy alone is generally considered curative. Once cells have invaded the submucosa, the polyp is staged as T1, and the decision becomes more nuanced.6PubMed Central. Malignant colorectal polyps
For a T1 malignant polyp on a stalk (pedunculated), complete removal during colonoscopy can still be curative if the cancer cells are well-differentiated, there is no sign of spread into blood vessels or lymph channels, and the edges of the removed tissue are clear of tumor. A flat (sessile) malignant polyp at the same stage is considered higher risk and typically prompts surgical resection of the affected segment of colon.6PubMed Central. Malignant colorectal polyps The pathology report will also note tumor size, degree of differentiation, and the distance between cancer cells and the resection margin, all of which influence the recommended next steps.7Europe PMC. Malignant Colorectal Polyps; Pathological Consideration (A review)
Does It Matter Where in the Colon a Polyp Sits?
Location turns out to matter quite a bit, especially when cancer is already present in the polyp. Research comparing outcomes after polypectomy versus surgical resection found that for early cancers in the left (distal) colon, removing the polyp endoscopically yielded survival rates comparable to surgery regardless of tumor size. But for early cancers in the right (proximal) colon larger than about 2 centimeters, surgery produced considerably better long-term survival than polypectomy alone.8PubMed. Polypectomy versus surgery in early colon cancer: size and location of colon cancer affect long-term survival
A separate large study examining more than 31,000 patients with early-stage colon cancer confirmed this pattern. After polypectomy, five-year cancer-specific survival was lower for proximal polyps than for distal ones, a gap that largely disappeared when patients had surgery instead.9PubMed. The Role of Tumor Location on Endoscopic and Surgical Management of Malignant Colon Polyps Part of the explanation is biological: right-sided colon cancers tend to have different molecular features than left-sided ones, and the lymph node drainage patterns differ. Part of it is practical: flat, broad-based polyps are more common on the right side, making complete endoscopic removal harder.
Polyps Outside the Colon
Although the colon gets the most attention, polyps form in many other parts of the body, and the relationship to tumors varies with each location.
Endometrial polyps grow from the lining of the uterus. They are overwhelmingly benign and typically cause irregular bleeding rather than pain. They are biologically distinct from uterine fibroids, which are benign tumors that arise from the muscular wall of the uterus rather than the lining. Despite their different origins, research has found a small set of genes that are abnormally active in both conditions, suggesting some shared disruption in the tissue environment.10PubMed Central. Comparative transcriptomic analysis of endometrial tissue associated with uterine fibroids and endometrial polyps The practical difference for patients: endometrial polyps can usually be removed in a brief outpatient procedure, while fibroids embedded deep in the uterine wall sometimes require more involved surgery.
Nasal polyps are soft, painless growths that hang from the lining of the nasal passages or sinuses, usually linked to chronic inflammation from allergies, asthma, or recurrent infections. They are not tumors and carry essentially no cancer risk. However, the nasal cavity can also develop a separate entity called a sinonasal papilloma, a rare benign neoplasm that arises from the specialized lining of the nose and sinuses. Sinonasal papillomas come in several subtypes, including the inverted variety, which has a well-documented potential for malignant transformation and requires surgical removal with careful follow-up.11Europe PMC. Giant Oncocytic Sinonasal Papilloma: A Rare Case The lesson here applies broadly: two growths in the same organ can look similar to the naked eye but behave in completely different ways under a microscope.
Hereditary Syndromes That Blur the Line
For most people, a polyp is an isolated event discovered during a routine screening. For people with certain inherited genetic conditions, polyps are a lifelong, recurring problem that dramatically raises cancer risk. The most well-known is familial adenomatous polyposis, or FAP, caused by inherited mutations in that same APC gene discussed earlier. People with FAP can develop hundreds or even thousands of adenomatous polyps in the colon beginning in their teens, and without intervention, colorectal cancer is virtually inevitable.12PubMed Central. Mechanism of APC truncation involved in colorectal cancer tumorigenesis
Because the cancer risk is so high and arrives so early, care for these patients centers on prevention. That often means removing the colon entirely, usually in early adulthood, before any polyp has the chance to progress. The timing and extent of surgery remain a subject of ongoing debate among surgeons.13PubMed. Controversies in the surgery of patients with familial adenomatous polyposis and Lynch syndrome Lynch syndrome, another inherited condition, raises colorectal cancer risk through a different mechanism involving defective DNA mismatch repair, and surveillance for these patients is more frequent than for the general population.
If a doctor finds an unusually large number of polyps in a young patient, genetic testing is now standard practice. Identifying one of these syndromes changes not only the patient’s care plan but also has implications for their relatives, who may carry the same mutation.
How Doctors Evaluate a Polyp in Real Time
During a colonoscopy, the endoscopist often needs to make a judgment call before the pathology results come back: does this polyp look benign, or does it look like something that needs more aggressive removal? Modern endoscopy uses image-enhancement technologies, including narrow-band imaging and magnification, that highlight the surface patterns and blood-vessel architecture of a polyp. Standardized classification systems help endoscopists predict whether a polyp is benign, low-grade, or deeply invasive. One widely used system achieves about 90% accuracy for distinguishing neoplastic from non-neoplastic polyps, though its sensitivity for detecting deeply invasive cancer is considerably lower.14Clinical Endoscopy. Classification of image-enhanced endoscopy in colon tumors
That gap in sensitivity is important. An endoscopist who sees a large, flat lesion on the right side of the colon may suspect deep invasion but cannot be certain until the tissue is examined by a pathologist. This is one reason why larger or suspicious-looking polyps are sometimes tattooed with ink at the time of colonoscopy, so that if the pathology later shows cancer, the surgeon can locate the exact spot during a follow-up operation.
Surveillance After Polyp Removal
Once a polyp has been removed and found to contain cancer, follow-up colonoscopy is typically recommended sooner than it would be for a simple adenoma. For patients who have had colorectal cancer surgically resected, guidelines have shifted toward performing the first post-surgical colonoscopy at one year rather than three, driven by data showing a small but meaningful incidence of new cancers appearing within the first two years after surgery.15ScienceDirect (Elsevier). Cost-effectiveness of early colonoscopy surveillance after cancer resection
For patients whose polyps were entirely benign or low-risk adenomas, the intervals are longer, often three to five years or even ten years for people with only small hyperplastic polyps. These timelines reflect the slow pace at which a brand-new polyp would need to develop and progress. Your doctor’s recommendation for when to schedule your next colonoscopy is essentially a risk calculation based on the number, size, type, and location of the polyps that were found.
Polyps and Tumors in Pets
The polyp-to-tumor distinction is not unique to human medicine. Dogs and cats develop gastrointestinal polyps and tumors that parallel many of the same categories seen in people. In veterinary pathology, intestinal polyps in cats and dogs are evaluated with similar attention to cell type, invasiveness, and location. Some of the molecular pathways involved in colorectal carcinogenesis in humans have analogs in companion animals, which is one reason veterinary oncologists use comparable staging systems. If your vet mentions a polyp found in your pet’s colon or rectum, the same basic question applies: is it a benign overgrowth, or does it show signs of neoplastic change? Biopsy and histopathology guide the answer, just as they do in human medicine.